MDSCs are involved in the protumorigenic potentials of GM-CSF in colitis-associated cancer.

MDSCs are involved in the protumorigenic potentials of GM-CSF in colitis-associated cancer.
复制标题

DOI:
10.1177/0394632017711055
复制
发表时间:
2017-06
影响因子:
3.5
通讯作者:
Liu Z
Liu Z
中科院分区:
医学4区
文献类型:
--
作者:
Ma N;Liu Q;Hou L;Wang Y;Liu Z

文献摘要

参考文献

被引文献

相似文献

慢性炎症被认为是结肠炎相关性结直肠癌(CAC)发展的主要驱动力。粒细胞巨噬细胞集落刺激因子(GM-CSF)作为促炎细胞因子家族的一员,近年来被证实在CAC的发病机制中起着关键作用。然而,潜在的机制在很大程度上仍然不为人知。在这项研究中,我们发现在从结肠炎到癌症的发展过程中,髓系来源的抑制细胞(MDSCs)在病变中积累越来越多,这对CAC的形成至关重要。重要的是,这种MDSC的聚集是由GM-CSF控制的。经CAC诱导后,GM-CSF缺陷小鼠的MDSC数量显著减少,将野生型CAC小鼠的MDSC输注到GM-CSF缺陷小鼠体内可导致CAC复发。此外,仅CAC病变或GM-CSF的上清液就足以将造血祖细胞分化为MDSCs。加入中和抗GM-CSF抗体可削弱CAC病变上清液对MDSC的分化作用。总体而言,这些发现通过诱导/招募促进CAC的MDSC,为了解GM-CSF在CAC发生中的作用机制提供了新的见解。阻断GM-CSF活性或MDSC功能可能代表CAC临床治疗的新策略。
Chronic inflammation is thought to be a major driving force for the development of colitis-associated colorectal cancer (CAC). As one member of proinflammatory cytokine family, granulocyte macrophage colony-stimulating factor (GM-CSF) has been identified to play a key role in CAC pathogenesis recently. The underlying mechanisms, however, remain largely unknown. In this study, we found that myeloid-derived suppressor cells (MDSCs) accumulated increasingly in the lesions during the progression from colitis to cancer, which was critical for CAC formation. Importantly, this MDSC accumulation was controlled by GM-CSF. MDSC number decreased significantly in GM-CSF-deficient mice suffering from CAC induction, and transfusion of MDSCs from wild-type CAC-bearing mice into GM-CSF-deficient counterparts led to recurrence of CAC. Furthermore, the supernatants of CAC lesions or GM-CSF alone was sufficient to differentiate hematopoietic precursors into MDSCs. Addition of neutralizing anti-GM-CSF antibody impaired the MDSC-differentiating effects of the supernatants of CAC lesions. Overall, these findings shed new insights into the mechanisms of GM-CSF underlying CAC development, by inducing/recruiting CAC-promoting MDSCs. Blocking GM-CSF activity or MDSC function may represent new therapeutic strategies for CAC in clinic.
DOI: 10.1158/0008-5472.can-04-0757
发表时间: 2004-09-01
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Serafini, P;Carbley, R;Borrello, I
通讯作者: Borrello, I
DOI: 10.1084/jem.20080132
发表时间: 2008-09-29
期刊: The Journal of experimental medicine
影响因子: --
作者:
Cheng P;Corzo CA;Luetteke N;Yu B;Nagaraj S;Bui MM;Ortiz M;Nacken W;Sorg C;Vogl T;Roth J;Gabrilovich DI
通讯作者: Gabrilovich DI
DOI: 10.1126/science.8171324
发表时间: 1994-04-29
期刊: SCIENCE
影响因子: 56.9
作者:
DRANOFF, G;CRAWFORD, AD;MULLIGAN, RC
通讯作者: MULLIGAN, RC
DOI: 10.1016/j.ccr.2009.01.001
发表时间: 2009-02-03
期刊: Cancer cell
影响因子: 50.3
作者:
Grivennikov S;Karin E;Terzic J;Mucida D;Yu GY;Vallabhapurapu S;Scheller J;Rose-John S;Cheroutre H;Eckmann L;Karin M
通讯作者: Karin M
DOI: 10.1016/s0021-9673(00)01206-1
发表时间: 2001-04-13
影响因子: 4.1
作者:
Tcherkas, YV;Kartsova, LA;Krasnova, IN
通讯作者: Krasnova, IN